Home
Michael Thomas Henderson, CEO: Apogee Therapeutics APGE Sell · Filed 24/12/06
Trade details
- Type
- Insider sale
- Amount
- $619,752
- Shares · price
- 13,328 sh · $46.50 a share
- Held after
- 1,326,159 sh
- Trade date
- 24/12/04
- Filed
- 24/12/06
- Days to filing
- 2 days
Sold 1.0% of holdings
- Share of holding sold
- 1.0%
Apogee Therapeutics trades, last 26 weeks
What else happened in Apogee Therapeutics around then
Filed or reported within 30 days of the trade day · 24/11/04~25/01/03Michael Thomas Henderson's recent trades
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 planSpyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
- Michael Thomas Henderson
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10
